Universal Health Realty Income Trust (UHT) investor relations material

Executive summary

• Q3 2026 net income was $4.9m vs. $4.0m and diluted EPS was $0.35 vs. $0.29; 9M net income was $15.9m, including a $724k land-sale gain.

• 9M adjusted net income excluding the land-sale gain was $15.1m, or $1.09/share.

• Q3 FFO was $12.3m, or $0.88/diluted share, vs. $12.2m and $0.88; 9M FFO was $37.1m, or $2.67/share, vs. $35.9m and $2.59.

Financial highlights

• Q3 revenue was $25.346m vs. $25.302m; 9M revenue was $74.866m vs. $74.718m.

• Q3 net interest expense fell to $4.529m from $4.816m; 9M expense fell to $13.429m from $14.202m.

• 9M operating cash flow was $33.5m vs. $35.5m; dividends paid were $31.2m vs. $30.7m.

• 9M adjusted net income increased $1.8m YoY, reflecting higher property income and lower interest expense, partly offset by the prior-year settlement benefit.

Outlook and guidance

• Miller Medical Plaza construction is expected to finish in December 2026 at an estimated cost of $34m; a 10-year UHS master flex lease covers ~75% of rentable area and begins at completion.

• UHS gave notice to renew the McAllen and Wellington leases for five years from January 2027; renewals are expected to be finalized in Q4 2026.

• The October Chicago land sale is expected to generate a $1.90m gain in Q4 2026; the parcel was ~42% of remaining acreage at September 30.

• Interest expense is expected to increase significantly when the $55m swap matures in March 2027; available operating cash, cash balances, credit and capital-market access are expected to cover needs for 12 months.